From a study by D. Aldridge, W. Schmid, M. Kaeder, C. Schmidt, and T. Ostermann
Material and methods: Twenty multiple sclerosis patients (14 female, 6 male) were involved in the study, their ages ranging from 29 to 47 years. Ten participants formed the therapy group, and 10 the matched control group matched by age, gender and the standard neurological classification scheme Expanded Disability Status Scale (EDSS). Exclusion criteria were pregnancy and mental disorders requiring medication. Patients in the therapy group received three blocks of music therapy in single sessions over the course of the one-year project (8—10 sessions, respectively). Measurements were taken before therapy began (U1), and subsequently every three months (U2—U4) and within a 6-month follow-up without music therapy (U5) after the last consultation. Test battery included indicators of clinical depression and anxiety (Beck Depression Inventory and Hospital Anxiety and Depression Scale), a self-acceptance scale (SESA) and a life quality assessment (Hamburg Quality of Life Questionnaire in Multiple Sclerosis). In addition, data were collected on cognitive (MSFC) and functional (EDSS) parameters.
Results: There was no significant difference between the music-therapy treatment group and the control group. However, the effect size statistics comparing both groups show a medium effect size on the scales measuring self-esteem (d, 0.5423), depression HAD-D (d, 0.63) and anxiety HAD-A (d, 0.63). Significant improvements were found for the therapy group over time (U1—U4) in the scale values of self-esteem, depression and anxiety. At follow-up, scale values for fatigue, anxiety and self-esteem worsen within the group treated with music therapy. [emphasis added]Discussion: A therapeutic concept for multiple sclerosis, which includes music therapy, brings an improvement in mood, fatigue and self-acceptance. When music therapy is removed, then scale scores worsen and this appears to intimate that music therapy has an influence. [emphasis added]
Outcome measures over time. U1—U4: treatment phase, U5: follow-up. Dashed line: control-group, full-line: music-therapy group. BDI: Beck Depression Inventory, HADS-A: Hospital Anxiety and Depression Scale—–anxiety, SESA: Scale for self-acceptance (SESA), IFFS: Incapacity and Fatigue Scale.
I could not find on Dr. Aldridge’s web site a way to make contact with him as the principal author of this study to let him know I have quoted this. However, I find it interesting that with all the studies available in the literature on the effects of classical music on the brain, that no-one else has yet thought to apply classical music as a therapeutic intervention in multiple sclerosis. Unfortunately this paper does not include the details of what exactly the music therapy in the study consisted of. However, since the addition of music to an afflicted individual’s environment is low-cost, safe, and non-invasive, it seems to make sense that given the other neurological research available, persons with MS should consider classical music as a positive addition to their environment. It is clear from this study that there are significant quality-of-life improvements, which vanish when music is discontinued. And since we know that quality of life is important in many aspects of health, we should welcome any improvements as being part of an overall strategy in health care.
This study is promising in another way, as well: since the effects were studied over only a short period of time, it’s quite possible that longer exposure would lead to more permanent effects. (After all, we all know what happens when we exercise or diet a few weeks, and fail to follow up!) I would love to see one-month, six-month, one- and five-year studies where the details of exactly what comprises the music therapy are made clear. In the meantime, listening and performing your daily activities to classical music can only help you, not hurt you!
Dr. Aldridge, if you happen to read this, please contact me via email.